YAP1 and metabolic syndrome: Intriguingly, besides the positive effects on all major hallmarks of the metabolic syndrome in obese mice, the treatment also prevented the loss of, or even increased skeletal muscle mass at least in part by activating the transcriptional coactivator and Hippo pathway effector yes-associated protein 1 (YAP1) in skeletal muscle.